Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates
Daniel A. King(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Calvin J. Kuo(Stratford University), Paolo Ocampo, Ari David Baron, S. Peter Goedegebuure(Washington University in St. Louis), Sheeno Thyparambil(Microprobes (United States)), William Hoos(Cancer Prevention Institute of California), Michitaka Nakano(Stratford University), Flavia Michelini(Memorial Sloan Kettering Cancer Center), Amber R. Smith(Stanford University), Malachi Griffith(Washington University in St. Louis), George A. Fisher(Stanford University), M. James Nichols(Saratoga Hospital), Trevor Ainge(Precision for Medicine (United States)), Jasreet Hundal(James S. McDonnell Foundation), William E. Gillanders(Washington University in St. Louis), George A. Poultsides(Stanford University), Haeseong Park(Brigham and Women's Hospital), Maddy Pollastro(Precision for Medicine (United States)), Carla Grandori(Precision for Medicine (United States)), Michele Cioffi(Spanish National Cancer Research Centre), Payel Chatterjee(Precision for Medicine (United States)), Rachele Rosati(Precision for Medicine (United States)), Marta Flory(Stanford University), Daniel T. Chang(National Tsing Hua University), Aaron K. McCormick(Stanford University), Joseph M. Herman(Northwell Health), Xiuli Zhang(Washington University in St. Louis), Jihang Ju(Stanford University), Wei‐Li Liao, Gino Pineda(Cancer Prevention Institute of California), Astrid Margossian(Precision for Medicine (United States)), Lee-may Chen(Apple (Israel))
Cited by 15
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
|The Journal of Experimental Medicine|2006|1.3k